Perbedaan Metro Healthcare Indonesia Tbk. dan Kalbe Farma Tbk: Metro Healthcare Indonesia Tbk. diperdagangkan di Rp428 (kapitalisasi pasar 14,23 T, volume 24 jam 346,3 rb), sedangkan Kalbe Farma Tbk diperdagangkan di Rp705 (kapitalisasi pasar 34,17 T, volume 24 jam 156,61 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 2,4× kapitalisasi pasar Metro Healthcare Indonesia Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (156,61 jt vs 346,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CARE | KLBF | |
|---|---|---|
Kapitalisasi Pasar | 14,23 T | 34,17 T |
Volume | 346,3 rb | 156,61 jt |
Lot | 3,46 rb | 1,57 jt |
Perputaran | 147,93 jt | 111,23 M |
Harga Rata-rata | 427,18 | 710,21 |
Nilai Transaksi | 147,93 jt | 111,23 M |
Harga Ekuilibrium Indikatif | 428 | 705 |
Volume Ekuilibrium Indikatif | 10 | 56,1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Selengkapnya di halaman CARE →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →